PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17892128-6	2007	The proliferation and suppressive function of the CD4+ CD25+ T cells coming from tumor-bearing mice was measured by [3H]-thymidines incorporation experiment in vitro, and then effect of CD4+ CD25+ T cells originated from hepatocellular carcinoma-bearing mice on tumor growth was observed in vivo.	Thymidine	121-131	CD4 antigen	Mus musculus	50-53	
19340309-8	2009	Taken together these results indicate an involvement of CD4(+) T-cells in J8-DT-mediated protection possibly via an ability to maintain antibody levels.	Thymidine	77-79	CD4 antigen	Mus musculus	56-59	
19160959-5	2008	The inhibitory role of the CD4+CD25+ T cells was assessed by [3H] thymidine incorporation method and the cytokines in the cultural supernatant were detected by ELISA.	Thymidine	66-75	CD4 antigen	Mus musculus	27-30	
20083650-4	2010	Of several founder lines, Foxp3.LuciDTR-4 mice displayed approximately 95% Treg depletion following injection of DT, resulting in activation of conventional CD4(+) T cells, probably due to lack of control by Tregs.	Thymidine	36-38	CD4 antigen	Mus musculus	157-160	
15728482-7	2005	Stimulation with anti-CD3 mAb induced transiently greater thymidine incorporation in IL-16-deficient CD4(+) T cells than wild-type controls, but there was no difference in cell survival or in the CFSE dilution profiles.	Thymidine	58-67	CD4 antigen	Mus musculus	101-104	
23861729-5	2013	Ovalbumin-specific CD4(+) DO11.10 and OT-II T cells that had been stimulated with their cognate antigen in the presence of OvALT-2 or OvNLT-1 displayed reduced DNA synthesis quantified by (3)H-thymidine incorporation and reduced cell division quantified by CFSE dilution.	Thymidine	193-202	CD4 antigen	Mus musculus	19-22